Unos nuevos datos confirman que el refuerzo actualizado de Pfizer se dirige a las variantes ómicron
VIERNES, 14 de octubre de 2022 (HealthDay News) — Los datos de un nuevo ensayo muestran que la vacuna de refuerzo contra la COVID actualizada de Pfizer es más potente contra las subvariantes de la ómicron que la vacuna original, anunció el jueves la …
Learn MoreNo Increase in GBS Seen After COVID-19 Vaccination in Adults
MONDAY, Oct. 17, 2022 (HealthDay News) — There is an increase in the reporting rate of Guillain-Barré syndrome (GBS) after COVID-19 vaccination, but the rate is within the incidence range for the general population, according to a study published onl…
Learn MoreIs Exercise Getting Tougher for You? Long COVID Might Be to Blame
MONDAY, Oct. 17, 2022 (HealthDay News) — After COVID-19, resuming regular exercise may be harder, and new research suggests this may be one more symptom of long COVID.For the study, the researchers reviewed 38 published studies that tracked the exerc…
Learn MoreWhat’s Keeping Some Hispanic Americans From Getting the COVID Shot?
MONDAY, Oct. 17, 2022 (HealthDay News) – While a large number of Hispanic Americans have received at least one dose of a COVID-19 vaccine at this point, a new study suggests barriers may still stand in the way for those who might want to get shots.Res…
Learn MoreNew Omicron Variants Gaining Foothold in U.S.
MONDAY, Oct. 17, 2022 (HealthDay News) – New, more contagious Omicron variants are starting to spread across the United States, new government data show.Luckily, they’re related to the Omicron variant BA.5, so recently updated booster shots should pro…
Learn MoreEven Without Symptoms, COVID Infection Raises Risks for Trauma Patients
MONDAY, Oct. 17, 2022 (HealthDay News) — Having COVID-19 could cause further trouble for patients being treated for physical trauma — even if they have no symptoms of the virus. Researchers studying cases of trauma patients who tested positive for CO…
Learn MorePfizer’s Updated Booster Targets Omicron Variants, New Data Confirm
FRIDAY, Oct. 14, 2022 (HealthDay News) — New trial data show that Pfizer’s updated COVID-19 booster shot is more powerful against omicron subvariants than the original shot, the company announced Thursday.”These early data suggest that our bivalent v…
Learn MorePaxlovid, un medicamento para la COVID, podría interactuar con medicamentos cardiacos
JUEVES, 13 de octubre de 2022 (HealthDay News) — Paxlovid, un antiviral para la COVID-19, ha sido un punto de inflexión en la pandemia global, al proteger a los pacientes con un riesgo alto de los efectos más devastadores del coronavirus.Pero el mism…
Learn MoreWith COVID Crisis Ebbing, How Can We Prevent Future Pandemics?
FRIDAY, Oct. 14, 2022 (HealthDay News) — Aggressive measures are needed in the world’s tropical regions to prevent the inevitable next global pandemic, an international coalition of researchers has concluded.Epidemics around the world have largely be…
Learn MorePfizer’s Updated Booster Targets Omicron Variants, New Data Confirms
FRIDAY, Oct. 14, 2022 (HealthDay News) — New trial data shows that Pfizer’s updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday.The findings are reassuring, since human data o…
Learn More